Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 75.0 | 64 | ||||
RA2159 | 2 | MIP-1B | 71.0 | 79 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 69.5 | 76 | ||||
N2645 | 2 | MIP-1B | 68.0 | 68 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 70.5 | 68 | ||||
RA2708 | 2 | MIP-1B | 68.0 | 74 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 89.5 | 78 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 100.0 | 59 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 80.0 | 79 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 87.5 | 84 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 92.0 | 65 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 88.5 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 134.0 | 79 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | MIP-1B | 148.5 | 72 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 86.5 | 72 | |
N2645 | TNF-a | 100 | ng/mL | 2 | MIP-1B | 91.0 | 70 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 102.0 | 71 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | MIP-1B | 98.0 | 39 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 73.0 | 62 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 76.0 | 67 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 70.0 | 89 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 69.0 | 64 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 66.0 | 68 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 79.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 290.5 | 70 |